Dubai Health partners with The Royal Marsden to advance clinical development at the Hamdan Bin Rashid Cancer Hospital - Dubai Health
Menu Display
-
- About Dubai Health
- News & Events
- Blog
- Careers
- FAQs
- Contact us
Menu Display
Menu Display
Menu Display
-
- About Dubai Health
- News & Events
- Blog
- Careers
- FAQs
- Contact us
Care
Facilities
Menu Display
Departments And Specialties
Menu Display
Patients And Visitors
Building on Dubai Health's vision to advance health for humanity, The Royal Marsden NHS Foundation Trust has been selected to support the clinical and operational development of the Hamdan Bin Rashid Cancer Hospital (HBRCH), Dubai's first integrated, comprehensive cancer hospital.
The partnership marks a significant step forward in enhancing the standard of cancer treatment in Dubai, where specialized and compassionate care will be accessible in one place.
As one of the world's leading hospitals dedicated to cancer diagnosis, treatment, research, and education, The Royal Marsden will work with Dubai Health to establish a model of excellence in comprehensive cancer care at HBRCH. Their renowned expertise will be leveraged across several key areas, including developing specialist, evidence-based models of care, early diagnosis, and treatment pathways that guide patients through every step of their journey.
The HBRCH program of care will span from early detection to treatment, recovery, and post-treatment support. A key focus of this partnership will be building a world-class, specialized team of cancer care professionals. This will involve creating a robust workforce plan, developing advanced training programmers, and fostering a culture of continuous learning. Additionally, the partnership will seek to establish a cancer research program, fostering a culture of discovering transformative advancements in cancer care.
Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Member of Dubai Health Board of Directors, said, “We are honored to join forces with The Royal Marsden, a global leader in cancer research and treatment. Their renowned expertise and approach to care perfectly complement the care, learning, discovery, and giving missions of our integrated academic health system. Through this partnership, we are honoring the collective generosity of our esteemed donors whose unwavering support to Al Jalila Foundation is fulfilling our vision for the Hamdan Bin Rashid Cancer Hospital to become a beacon of hope for patients and families facing a cancer diagnosis. It propels us closer to achieving the Dubai Social Agenda 33 goal of delivering a world-class healthcare system of the highest efficiency and quality."
Dame Cally Palmer, Chief Executive, The Royal Marsden, said: “I am delighted that The Royal Marsden has been chosen to work in partnership with Dubai Health to advance the clinical development of the Hamdan Bin Rashid Cancer Hospital. This is an excellent opportunity for international collaboration, and to adapt the best practices in state-of-the-art healthcare provision and establish the structure upon which this advanced, innovative and future-looking hospital can be based.”
“At The Royal Marsden our integrated NHS and Private Care model, underpinned by a research and academic infrastructure, delivers outstanding personalized care for our patients. Through a staged program of work, The Royal Marsden and Dubai Health aim to establish a long-term strategic partnership that will not only develop a new hospital but support specialized cancer care across the wider healthcare system in Dubai,” she added.
Set to open in 2026, the HBRCH will offer a groundbreaking model of care under Dubai Health. As part of Dubai’s first integrated academic health system, the comprehensive cancer hospital will create multidisciplinary teams to spearhead a transformative shift in care delivery. Research and clinical trials will be at the heart of the hospital, fostering a culture of discovery and accelerating progress in cancer care. With 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus, the hospital is positioned to become a beacon of hope for cancer patients in the UAE and the region.
April 04, 2024, Dubai: Al Jalila Foundation, which leads the giving mission of Dubai Health, announced that Saeed Ahmed Lootah Charity Foundation has donated AED 15 million to support the development of the Hamdan Bin Rashid Cancer Hospital, Dubai's first integrated, comprehensive cancer hospital. This donation underscores Saeed Ahmed Lootah Charity Foundation's commitment to advancing sustainable charitable and humanitarian work and reinforcing Dubai's pioneering role in healthcare excellence.
Set to open in 2026, the hospital honors the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum, paying tribute to his lifetime of service to the nation and extraordinary global philanthropic activities that continue to touch the lives of many around the world. The hospital is being developed with the support of generous donations received from philanthropists, government and non-government organizations, UAE businesses and corporates.
Engineer Hussain Nasser Lootah, Member of the Board of Trustees of the Saeed Ahmed Lootah Charity Foundation, said: “Inspired by our visionary leadership, which has embedded philanthropy into its core humanitarian strategies, the Saeed Ahmed Lootah Charity Foundation, led by H.E. Lieutenant General Dhahi Khalfan Tamim, Chairman of the Board of Trustees, remains committed to social responsibility, education, and medical research support. We are pleased to contribute towards the Hamdan Bin Rashid Cancer Hospital, aligning our efforts with Al Jalila Foundation to ensure equitable and essential access to cancer care. This partnership reflects the core principles of our esteemed founder, Haj Saeed Ahmed Lootah, who championed education, healthcare, and scientific research. Our dedication extends beyond borders, encompassing local and global charitable and humanitarian endeavors."
Dr. Thani Al Mheriri, CEO of Education & Health at Saeed Ahmed Lootah Charity Foundation, said: “By joining hands, we aim to make a meaningful impact in the fight against cancer and advancing medical research. Our dedication to medical education and healthcare is deeply rooted in our legacy; Dubai Medical College for Girls, which was established forty years ago as the first institution for medical education for girls in the Gulf region, is now a prominent contributor to the healthcare landscape."
Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “Donor support is an integral part of our success in developing the Hamdan Bin Rashid Cancer Hospital. We are grateful to Saeed Ahmed Lootah Charity Foundation, which has committed to helping us support cancer patients and their families. The hospital will bring together cancer expertise and make an invaluable contribution to Dubai’s healthcare sector, putting patient care first.”
"Together, we are one step closer to establishing a center of excellence that will transform cancer care in the UAE." he added.
The 116-bed hospital will occupy 56,000 square meters. It will provide best-in-class outpatient, ambulatory and diagnostic services as well as inpatient and surgical services in a nurturing environment that features personalized patient care.
As part of Dubai Health, the first integrated academic health system in Dubai, the comprehensive cancer hospital will benefit from a multidisciplinary team, including specialized nursing, offering patients a full spectrum of care services in one location, from early diagnosis to treatment and supportive care. Aligning with Dubai Health’s Patient First promise, select treatments and services will be made available to patients in the comfort of their homes, ensuring an easy and accessible continuum of care.
For more information on Al Jalila Foundation and its programs, please visit:
https://www.aljalilafoundation.ae